• Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion

  • 2024/01/25
  • 再生時間: 58 分
  • ポッドキャスト

Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion

  • サマリー

  • In this episode, Anthony and Bernie review the most impactful and interesting ALL abstracts at the 2023 ASH Annual Meeting. We dive into the nelarabine abstracts, calaspargase (cal-peg), and the evolution of the treatment of Ph+ ALL!


    Abstracts discussed:

    • https://ash.confex.com/ash/2023/webprogram/Paper190141.html - COG AYA Outcomes (and silly nelarabine conclusions)
    • https://ash.confex.com/ash/2023/webprogram/Paper177696.html - ATRIALL Nelarabine study
    • https://ash.confex.com/ash/2023/webprogram/Paper179562.html - HyperCVAD + Nelarabine + PEG + venetoclax
    • https://ash.confex.com/ash/2023/webprogram/Paper179192.html - ALL-TARGET Study in R/R T-ALL
    • https://ash.confex.com/ash/2023/webprogram/Paper187694.html - Cal-PEG is toxic
    • https://ash.confex.com/ash/2023/webprogram/Paper188064.html - Ponatinib + Blinatumomab
    • https://ash.confex.com/ash/2023/webprogram/Paper187773.html - D-ALBA (Dasatinib + Blinatumomab)
    • https://ash.confex.com/ash/2023/webprogram/Paper189632.html - GIMEMA (Dasatinib or Ponatinib + Blinatumomab)
    続きを読む 一部表示

あらすじ・解説

In this episode, Anthony and Bernie review the most impactful and interesting ALL abstracts at the 2023 ASH Annual Meeting. We dive into the nelarabine abstracts, calaspargase (cal-peg), and the evolution of the treatment of Ph+ ALL!


Abstracts discussed:

  • https://ash.confex.com/ash/2023/webprogram/Paper190141.html - COG AYA Outcomes (and silly nelarabine conclusions)
  • https://ash.confex.com/ash/2023/webprogram/Paper177696.html - ATRIALL Nelarabine study
  • https://ash.confex.com/ash/2023/webprogram/Paper179562.html - HyperCVAD + Nelarabine + PEG + venetoclax
  • https://ash.confex.com/ash/2023/webprogram/Paper179192.html - ALL-TARGET Study in R/R T-ALL
  • https://ash.confex.com/ash/2023/webprogram/Paper187694.html - Cal-PEG is toxic
  • https://ash.confex.com/ash/2023/webprogram/Paper188064.html - Ponatinib + Blinatumomab
  • https://ash.confex.com/ash/2023/webprogram/Paper187773.html - D-ALBA (Dasatinib + Blinatumomab)
  • https://ash.confex.com/ash/2023/webprogram/Paper189632.html - GIMEMA (Dasatinib or Ponatinib + Blinatumomab)

Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussionに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。